Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation
Chronic kidney disease (CKD) is one of the most important risk factors for cardiovascular disease (CVD). Despite the kidney having no direct implications for lipoproteins metabolism, advanced CKD dyslipidemia is usually present in patients with CKD, and the frequent lipid and lipoprotein alterations...
Main Authors: | Carlo Maria Barbagallo, Angelo Baldassare Cefalù, Antonina Giammanco, Davide Noto, Rosalia Caldarella, Marcello Ciaccio, Maurizio Rocco Averna, Emilio Nardi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/11/4/315 |
Similar Items
-
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases
by: Antonina Giammanco, et al.
Published: (2021-06-01) -
The pathophysiology of intestinal lipoprotein production
by: Antonina eGiammanco, et al.
Published: (2015-03-01) -
Lipoprotein metabolism abnormalities in patients with chronic renal insufficiency
by: Ali Abusrie Abdellah, et al.
Published: (2011-01-01) -
Role of Nutraceuticals in Hypolipidemic Therapy
by: Carlo M Barbagallo, et al.
Published: (2015-05-01) -
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
by: Laura D’Erasmo, et al.
Published: (2021-09-01)